1
|
Shevchenko V, Benn RA, Scholz R, Wei W, Pallavicini C, Klatzmann U, Alberti F, Satterthwaite TD, Wassermann D, Bazin PL, Margulies DS. A comparative machine learning study of schizophrenia biomarkers derived from functional connectivity. Sci Rep 2025; 15:2849. [PMID: 39843572 PMCID: PMC11754439 DOI: 10.1038/s41598-024-84152-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Accepted: 12/20/2024] [Indexed: 01/24/2025] Open
Abstract
Functional connectivity holds promise as a biomarker of schizophrenia. Yet, the high dimensionality of predictive models trained on functional connectomes, combined with small sample sizes in clinical research, increases the risk of overfitting. Recently, low-dimensional representations of the connectome such as macroscale cortical gradients and gradient dispersion have been proposed, with studies noting consistent gradient and dispersion differences in psychiatric conditions. However, it is unknown which of these derived measures has the highest predictive capacity and how they compare to raw functional connectivity specifically in the case of schizophrenia. Our study evaluates which connectome features derived from resting state functional MRI - functional connectivity, gradients, or gradient dispersion - best identify schizophrenia. To this end, we leveraged data of 936 individuals from three large open-access datasets: COBRE, LA5c, and SRPBS-1600. We developed a pipeline which allows us to aggregate over a million different features and assess their predictive potential in a single, computationally efficient experiment. We selected top 1% of features with the largest permutation feature importance and trained 13 classifiers on them using 10-fold cross-validation. Our findings indicate that functional connectivity outperforms its low-dimensional derivatives such as cortical gradients and gradient dispersion in identifying schizophrenia (Mann-Whitney test conducted on test accuracy: connectivity vs. 1st gradient: U = 142, p < 0.003; connectivity vs. neighborhood dispersion: U = 141, p = 0.004). Additionally, we demonstrated that the edges which contribute the most to classification performance are the ones connecting primary sensory regions. Functional connectivity within the primary sensory regions showed the highest discrimination capabilities between subjects with schizophrenia and neurotypical controls. These findings along with the feature selection pipeline proposed here will facilitate future inquiries into the prediction of schizophrenia subtypes and transdiagnostic phenomena.
Collapse
Affiliation(s)
- Victoria Shevchenko
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France.
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK.
- MIND Team, Inria Saclay, Université Paris-Saclay, Palaiseau, France.
- Neurospin, CEA, Gif-Sur-Yvette, France.
| | - R Austin Benn
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK
| | - Robert Scholz
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK
- Max Planck School of Cognition, Leipzig, Germany
- Wilhelm Wundt Institute for Psychology, Leipzig University, Leipzig, Germany
| | - Wei Wei
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK
| | - Carla Pallavicini
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France
- National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
- Department of Physics, Institute of Applied and Interdisciplinary Physics, University of Buenos Aires, Buenos Aires, Argentina
| | - Ulysse Klatzmann
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK
| | - Francesco Alberti
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK
| | | | - Demian Wassermann
- MIND Team, Inria Saclay, Université Paris-Saclay, Palaiseau, France
- Neurospin, CEA, Gif-Sur-Yvette, France
| | | | - Daniel S Margulies
- Cognitive Neuroanatomy Lab, INCC UMR 8002, CNRS, Université Paris Cité, Paris, France.
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, FMRIB Centre, University of Oxford, Oxford, UK.
| |
Collapse
|
2
|
Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA. Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis. Pharmacol Res 2024; 207:107338. [PMID: 39111558 DOI: 10.1016/j.phrs.2024.107338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Revised: 07/31/2024] [Accepted: 07/31/2024] [Indexed: 08/12/2024]
Abstract
Psychedelics have emerged as promising therapeutics for several psychiatric disorders. Hypotheses around their mechanisms have revolved around their partial agonism at the serotonin 2 A receptor, leading to enhanced neuroplasticity and brain connectivity changes that underlie positive mindset shifts. However, these accounts fail to recognise that the gut microbiota, acting via the gut-brain axis, may also have a role in mediating the positive effects of psychedelics on behaviour. In this review, we present existing evidence that the composition of the gut microbiota may be responsive to psychedelic drugs, and in turn, that the effect of psychedelics could be modulated by microbial metabolism. We discuss various alternative mechanistic models and emphasize the importance of incorporating hypotheses that address the contributions of the microbiome in future research. Awareness of the microbial contribution to psychedelic action has the potential to significantly shape clinical practice, for example, by allowing personalised psychedelic therapies based on the heterogeneity of the gut microbiota.
Collapse
Affiliation(s)
- Giorgia Caspani
- Michael Smith Laboratories, University of British Columbia, 2185 East Mall, East Mall, BC V6T 1Z4, Canada; Department of Microbiology and Immunology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z4, Canada; Centre for Blood Research, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z4, Canada; The Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada; The Vancouver Prostate Centre, Vancouver General Hospital, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada; Department of Medical Genetics, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z4, Canada; Department of Urologic Sciences, University of British Columbia, Gordon & Leslie Diamond Health Care Centre, Level 6, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada.
| | - Simon G D Ruffell
- Psychae Institute, Melbourne, Australia; School of Population and Global Health, University of Melbourne, 207 Bouverie St, Carlton, VIC 3053, Australia
| | - WaiFung Tsang
- Institute of Psychiatry, Psychology & Neuroscience, King'sCollege London, Department of Psychology, De Crespigny Park, London SE5 8AF, UK
| | - Nigel Netzband
- University of West of England, Frenchay Campus, Coldharbour Lane, Bristol BS16 1QY, UK
| | - Cyrus Rohani-Shukla
- Centre for Psychedelic Research, Imperial College London, Hammersmith Hospital, Du Cane Rd, London W12 0HS, UK
| | - Jonathan R Swann
- School of Human Development and Health, Faculty of Medicine, University of Southampton, 12 University Rd, Southampton SO17 1BJ, UK; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
| | - Wilfred A Jefferies
- Michael Smith Laboratories, University of British Columbia, 2185 East Mall, East Mall, BC V6T 1Z4, Canada; Department of Microbiology and Immunology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z4, Canada; Centre for Blood Research, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z4, Canada; The Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada; The Vancouver Prostate Centre, Vancouver General Hospital, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada; Department of Medical Genetics, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z4, Canada; Department of Urologic Sciences, University of British Columbia, Gordon & Leslie Diamond Health Care Centre, Level 6, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada.
| |
Collapse
|
3
|
Rocca P, Brasso C, Montemagni C, Del Favero E, Bellino S, Bozzatello P, Giordano GM, Caporusso E, Fazio L, Pergola G, Blasi G, Amore M, Calcagno P, Rossi R, Rossi A, Bertolino A, Galderisi S, Maj M. The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses. Schizophr Res 2024; 267:330-340. [PMID: 38613864 DOI: 10.1016/j.schres.2024.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 03/24/2024] [Accepted: 04/04/2024] [Indexed: 04/15/2024]
Abstract
Deficits in social cognition (SC) interfere with recovery in schizophrenia (SZ) and may be related to resting state brain connectivity. This study aimed at assessing the alterations in the relationship between resting state functional connectivity and the social-cognitive abilities of patients with SZ compared to healthy subjects. We divided the brain into 246 regions of interest (ROI) following the Human Healthy Volunteers Brainnetome Atlas. For each participant, we calculated the resting-state functional connectivity (rsFC) in terms of degree centrality (DC), which evaluates the total strength of the most powerful coactivations of every ROI with all other ROIs during rest. The rs-DC of the ROIs was correlated with five measures of SC assessing emotion processing and mentalizing in 45 healthy volunteers (HVs) chosen as a normative sample. Then, controlling for symptoms severity, we verified whether these significant associations were altered, i.e., absent or of opposite sign, in 55 patients with SZ. We found five significant differences between SZ patients and HVs: in the patients' group, the correlations between emotion recognition tasks and rsFC of the right entorhinal cortex (R-EC), left superior parietal lobule (L-SPL), right caudal hippocampus (R-c-Hipp), and the right caudal (R-c) and left rostral (L-r) middle temporal gyri (MTG) were lost. An altered resting state functional connectivity of the L-SPL, R-EC, R-c-Hipp, and bilateral MTG in patients with SZ may be associated with impaired emotion recognition. If confirmed, these results may enhance the development of non-invasive brain stimulation interventions targeting those cerebral regions to reduce SC deficit in SZ.
Collapse
Affiliation(s)
- Paola Rocca
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Via Cherasco, 15, 10126 Turin, Italy
| | - Claudio Brasso
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Via Cherasco, 15, 10126 Turin, Italy.
| | - Cristiana Montemagni
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Via Cherasco, 15, 10126 Turin, Italy
| | - Elisa Del Favero
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Via Cherasco, 15, 10126 Turin, Italy
| | - Silvio Bellino
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Via Cherasco, 15, 10126 Turin, Italy
| | - Paola Bozzatello
- Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Via Cherasco, 15, 10126 Turin, Italy
| | - Giulia Maria Giordano
- Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Largo Madonna Delle Grazie, 1, 80138 Naples, Italy
| | - Edoardo Caporusso
- Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Largo Madonna Delle Grazie, 1, 80138 Naples, Italy
| | - Leonardo Fazio
- Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Policlinico, Piazza G. Cesare, 11, 70124 Bari, Italy; Department of Medicine and Surgery, LUM University, Strada Statale 100, 70010 Casamassima (BA), Italy
| | - Giulio Pergola
- Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Policlinico, Piazza G. Cesare, 11, 70124 Bari, Italy
| | - Giuseppe Blasi
- Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Policlinico, Piazza G. Cesare, 11, 70124 Bari, Italy
| | - Mario Amore
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, Section of Psychiatry, University of Genoa, Largo Paolo Daneo, 3, 16132 Genoa, Italy
| | - Pietro Calcagno
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, Section of Psychiatry, University of Genoa, Largo Paolo Daneo, 3, 16132 Genoa, Italy
| | - Rodolfo Rossi
- Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, via Vetoio - Coppito, 67100 L'Aquila, Italy; Policlinico Tor Vergata, Viale Oxford, 81, 00133 Rome, Italy
| | - Alessandro Rossi
- Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, via Vetoio - Coppito, 67100 L'Aquila, Italy
| | - Alessandro Bertolino
- Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Policlinico, Piazza G. Cesare, 11, 70124 Bari, Italy
| | - Silvana Galderisi
- Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Largo Madonna Delle Grazie, 1, 80138 Naples, Italy
| | - Mario Maj
- Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Largo Madonna Delle Grazie, 1, 80138 Naples, Italy
| |
Collapse
|